These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10852671)

  • 1. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Tsuchida E
    Artif Cells Blood Substit Immobil Biotechnol; 2000 May; 28(3):v-vii; discussion viii-xii. PubMed ID: 10852671
    [No Abstract]   [Full Text] [Related]  

  • 2. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Chengmin Y
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jul; 28(4):v-vi. PubMed ID: 10928698
    [No Abstract]   [Full Text] [Related]  

  • 3. Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy? A research perspective.
    Alayash AI
    Artif Cells Blood Substit Immobil Biotechnol; 2001 Jan; 29(1):1-3. PubMed ID: 11280680
    [No Abstract]   [Full Text] [Related]  

  • 4. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Feola M; Simoni J
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Mar; 28(2):vii-ix. PubMed ID: 10728579
    [No Abstract]   [Full Text] [Related]  

  • 5. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Mar; 28(2):v-vi. PubMed ID: 10728577
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):v-xi. PubMed ID: 10676573
    [No Abstract]   [Full Text] [Related]  

  • 7. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Chen HS
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Mar; 28(2):vii. PubMed ID: 10728578
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a need for blood substitutes in the new millennium, and what should we expect in the way of safety and efficacy? A development perspective.
    Hsia CJ
    Artif Cells Blood Substit Immobil Biotechnol; 2001 May; 29(3):vii-x. PubMed ID: 11358041
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and utility of blood substitutes.
    Winslow RM
    Dev Biol (Basel); 2000; 102():167-82. PubMed ID: 10794104
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transfusion of erythrocyte substitutes: products, indications, alternatives. General methods and recommendations].
    Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)
    Transfus Clin Biol; 2002; 9(5-6):333-56. PubMed ID: 12555753
    [No Abstract]   [Full Text] [Related]  

  • 11. What ever happened to blood substitutes?
    Stowell CP
    Transfusion; 2004 Oct; 44(10):1403-4. PubMed ID: 15383010
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood substitutes in surgery.
    Burris D
    Ann Chir Gynaecol; 2001; 90(2):76-80. PubMed ID: 11459262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen therapeutics ("blood substitutes") where are they, and what can we expect?
    Keipert PE
    Adv Exp Med Biol; 2003; 540():207-13. PubMed ID: 15174622
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood substitutes: oxygen-carrying acellular fluids.
    Wohl JS; Cotter SM
    Vet Clin North Am Small Anim Pract; 1995 Nov; 25(6):1417-40. PubMed ID: 8619274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions.
    Spahn DR
    Crit Care; 1999; 3(5):R93-7. PubMed ID: 11094488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorinated blood substitutes and artificial oxygen carriers.
    Lowe KC
    Blood Rev; 1999 Sep; 13(3):171-84. PubMed ID: 10527269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future prospects for artificial blood.
    Chang TM
    Trends Biotechnol; 1999 Feb; 17(2):61-7. PubMed ID: 10087605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical considerations concerning South Africa's approval of a blood substitute.
    Schutte AE
    Ethics Med; 2002; 18(2):55-62. PubMed ID: 14700041
    [No Abstract]   [Full Text] [Related]  

  • 19. A brand new bag. Trauma-care revolution among benefits touted as blood substitute enters critical phase of clinical trials.
    Becker C
    Mod Healthc; 2004 Apr; 34(15):30-1, 34. PubMed ID: 15124419
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxygen carriers ("blood substitutes").
    Topfer LA; Hailey D
    Issues Emerg Health Technol; 2001 Jul; (21):1-6. PubMed ID: 11776287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.